BioPharm March eBook - Outsourcing Resources

Issue link:

Contents of this Issue


Page 23 of 34

24 BioPharm International eBook March 2018 Outsourcing Resources Contract Biomanufacturing Bigger is Better in Samsung's Approach to Biomanufacturing A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics. RITA PETERS T he i n for m at ion te c h nolog y i ndu st r y i s noted for rapid development of innovative new products and advanced manufacturing practices that produce affordable products. The impact of digital technologies can be found in all areas of consumer, transportation, man- ufacturing, and business life. Dig ital technolog ies and information sciences also have helped advanced medical science and research, a lesson that was obvious to Dr. Tae Han K i m, CEO a nd president of Sa msu ng BioL og ics, when he was researching new business areas for Samsung about 10 years ago. His recommendation— to enter the biologics drug contract manufacturing market, an area in which it had no prior experi- ence—leveraged the company's manufacturing and plant construction expertise. While solar power, electric cars, or LED lighting may have been obvious choices for the diversified i ndust r ia l a nd technolog y conglomerate k now n widely for its consumer electronics and appliances, Kim observed that the biotech industry was at a ITSMEJUST/SHUTTERSTOCK.COM

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm - BioPharm March eBook - Outsourcing Resources